Cas 1128256-52-9,1-[6-(2-{[4-(4-chlorophenoxy)benzyl]oxy}phenyl)pyridin-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid

1128256-52-9

Post Buying Request

Basic information

Product Name: 1-[6-(2-{[4-(4-chlorophenoxy)benzyl]oxy}phenyl)pyridin-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid
Synonyms: 1-[6-(2-{[4-(4-chlorophenoxy)benzyl]oxy}phenyl)pyridin-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid
CAS NO:1128256-52-9
Molecular Formula:
Molecular Weight: 565.936
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-[6-(2-{[4-(4-chlorophenoxy)benzyl]oxy}phenyl)pyridin-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid(CAS DataBase Reference)
NIST Chemistry Reference: 1-[6-(2-{[4-(4-chlorophenoxy)benzyl]oxy}phenyl)pyridin-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid(1128256-52-9)
EPA Substance Registry System: 1-[6-(2-{[4-(4-chlorophenoxy)benzyl]oxy}phenyl)pyridin-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid(1128256-52-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1128256-52-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1128256-52-9 Suppliers

Recommended suppliers

1128256-52-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1128256-52-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,8,2,5 and 6 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1128256-52:
(9*1)+(8*1)+(7*2)+(6*8)+(5*2)+(4*5)+(3*6)+(2*5)+(1*2)=139
139 % 10 = 9
So 1128256-52-9 is a valid CAS Registry Number.

1128256-52-9Upstream product

1305150-75-7 C₃₁H₂₃ClF₃N₃O₄

1128256-52-9Downstream Products

1128256-52-9Relevant academic research and scientific papers

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

-

Page/Page column 20, (2009/09/05)

A compound having the structure useful for treatment or prevention of cardiovascular diseases, endothelial dysfunction, diastolic dysfunction, atherosclerosis, hypertension, angina pectoris, thromboses, restenoses, myocardial infarction, strokes, cardiac insufficiency, pulmonary hypertonia, erectile dysfunction, asthma bronchiale, chronic kidney insufficiency, diabetes, or cirrhosis of the liver in a human or animal patient.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1128256-52-9